Arkolith/Insider Trading/LYRA/Form 4

Waksal Harlan

Executive Chair, DirectorLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed Apr 13, 2022
Net Buying
Open-Market Buys
$1000K
Open-Market Sells
$0
Net Open-Market Flow
$1000K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 12, 2022Buy(P)237K$4.22$1000K237K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-014737) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML